Research
Awards Grant
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership - Administrative Core
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership - Pilot Project #1
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership - Pilot Project #2
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership - Training and Education
3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership
3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership - Investigating Race-Related Microbial Influences in Triple Negative Breast Cancer
3D-Microtumor_GBM Xenoline Proband Modeling of Kinome-Directed Therapy
A Druggable Chromatin Modifier Pathway in HCC
A Genome-Wide Methylation Study of Epigenetic Contributions to Multiple Myeloma
A Novel Druggable Genetic Vulnerability Pathway in Melanoma
A Novel Epigenetic Immunotherapy for Ovarian Cancer Treatment
A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma
A Phase I Study to Evaluate the Safety and Immunogenicity of HPV 16 L2 11-200
A20 Promotes Glioma Stem Cell Mediated Tumorigenesis
Active - Administrative Core - Comprehensive Cancer Center Core Support Grant
Active - Biostatistics and Bioinformatics - Comprehensive Cancer Center Core Support Grant
Active - Comprehensive Cancer Center Core Support Grant - Alabama HPV Vaccination Coalition Supplement
Active - Comprehensive Cancer Center Core Support Grant - Comprehensive Genomics SF (Hudson Alpha)
Active - Comprehensive Genomics Shared Facility - Comprehensive Cancer Center Core Support Grant
Active - Data Safety and Monitoring - Comprehensive Cancer Center Core Support Grant
Active - Developmental Funds - Comprehensive Cancer Center Core Support Grant
Active - High Resolution Imaging - Comprehensive Cancer Center Core Support Grant
Active - Human Imaging - Comprehensive Cancer Center Core Support Grant
Active - Major Program Leader - Comprehensive Cancer Center Core Support Grant
Active - NCI Clinical Trial Reporting Program - Comprehensive Cancer Center Core Support Grant
Active - Planning and Evaluation - Comprehensive Cancer Center Core Support Grant
Active - Proteomics - Comprehensive Cancer Center Core Support Grant
Active - Protocol Review & Monitoring - Comprehensive Cancer Center Core Support Grant
Active - Protocol Specific Research Support - Comprehensive Cancer Center Core Support Grant
Active - Recruitment & Retention - Comprehensive Cancer Center Core Support Grant
Active - Self-Collection & HPV Testing in Unscreened Women: A Feasibility Study in Brazil - Comprehensive Cancer Center Core Support Grant
Active - Senior Leadership - Comprehensive Cancer Center Core Support Grant
Active - Small Animal Imaging - Comprehensive Cancer Center Core Support Grant
Active - Structural Bilology SF Molecular NMR - Comprehensive Cancer Center Core Support Grant
Active - Structural Biology SF X-Ray Crystallography - Comprehensive Cancer Center Core Support Grant
Active - Tissue Procurement - Comprehensive Cancer Center Core Support Grant
Active - Transgenic Animal/Embryonic Stem Cell - Comprehensive Cancer Center Core Support Grant
Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health
Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health - ADI Core
Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health - Administrative Core
Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health - Assessment Core
Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health - Project 1
Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health - Project 2
Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health - Recruitment Core
Adapting MultiPLe Behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health- Project 3
Admin. Supp to Strengthen NCI-Supported Comm. Outreach Capacity Through Comm. Health Educators (CHEs) of the NON
Armed Replicating Ad for Breast Cancer Bone Metastasis
BMT Survivor Study-2 (BMTSS-2)
Biological Chemistry of Reactive Nitrogen Species Signaling in Cancer Etiology
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress
Biological Definition of FCRL Molecules in Malignancy
Biomechanics of the Stromal Regulation of DCIS
C-Src Kinase/Calmodulin Interaction: A Therapeutic Target for Pancreatic Cancer
CD147 as a Novel Target in Head and Neck Cancer
COMPLETED - Comprehensive Cancer Center Core Support Grant - Clinical Protocol and Data Management Shared Facility
COMPLETED - Comprehensive Cancer Center Core Support Grant - Neuro-Oncology Program
COMPLETED - Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Biostatistics/Bioinformatics Shared Resource
Cancer Clinical Investigator Team Leadership Award
Cancer Prevention & Control Training Program
Cancer Prevention & Control Training Program
Cancer Prevention and Control Training Program
Canine Immuno Neurotherapeutics
Cellular and Biologic Origins in CLL
Cervical Cancer Derived Xenografts (PDX) and Organoid Raft Cultures to Evaluate Pathway Specific Therapeutic Agents.
Cervical Cancer Prevention in Latina Immigrants
Cervical Cancer Preventive Measures Based on HPV 16 Epigenome
Chemoprevention of Breast Cancer with Rexinoids that Inhibit Obesity-Induced Metabolic Syndrome
Collaborative Human Tissue Network
Combinatorial Approach for Reducing Invasive Potential of Melanoma Cells
Combinatorial Epigenetic-Based Prevention of Breast Cancer
Common Variable Immune Deficiency (CVID) Project
Completed - Comprehensive Cancer Center Core Support Grant - DNA Sequencing SF
Completed - Comprehensive Cancer Center Core Support Grant - HIV Malignancy
Completed - Comprehensive Cancer Center Core Support Grant - Micro Array SF
Completed - Comprehensive Cancer Center Core Support Grant - NCI Clinical Trials Reporting Program (CTRP)
Completed - Comprehensive Genomics Shared Facility - Comprehensive Cancer Center Core Support Grant
Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukemia
Comprehensive Cancer Center Core Support Grant
Comprehensive Cancer Center Core Support Grant
Comprehensive Cancer Center Core Support Grant
Comprehensive Cancer Center Core Support Grant
Comprehensive Cancer Center Core Support Grant
Comprehensive Cancer Center Core Support Grant - Adiministrative Core
Comprehensive Cancer Center Core Support Grant - Admin Supplements to Stimulate Research in Non-AIDS Defining Cancers (NADCs) in Aging Populations
Comprehensive Cancer Center Core Support Grant - Administration
Comprehensive Cancer Center Core Support Grant - Administrative Core
Comprehensive Cancer Center Core Support Grant - Administrative Core
Comprehensive Cancer Center Core Support Grant - Administrative Supplement to Stimulate Research in HIV/AIDS Cancer Research
Comprehensive Cancer Center Core Support Grant - Administrative Supplement to Stimulate Research in HIV/AIDS Cancer Research
Comprehensive Cancer Center Core Support Grant - Administrative Supplement to Support Participation in the Experimental Therapeutics Clinical Trials Network (ETCTN)
Comprehensive Cancer Center Core Support Grant - Administrative Supplements to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators (CHEs)
Comprehensive Cancer Center Core Support Grant - Administrative Supplements to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators (CHEs) of the National Outreach Network (NON)
Comprehensive Cancer Center Core Support Grant - Administrative Supplemet
Comprehensive Cancer Center Core Support Grant - Biostatistics and Bioinformatics Shared Facility
Comprehensive Cancer Center Core Support Grant - Biostatistics and Bioinformatics Shared Facility
Comprehensive Cancer Center Core Support Grant - Biostatistics and Bioinformatics Shared Facility
Comprehensive Cancer Center Core Support Grant - Biostatistics/Bioinformatics
Comprehensive Cancer Center Core Support Grant - Cancer Cell Biology Program
Comprehensive Cancer Center Core Support Grant - Cancer Cell Biology Program
Comprehensive Cancer Center Core Support Grant - Cancer Cell Biology Program
Comprehensive Cancer Center Core Support Grant - Cancer Chemoprevention Program
Comprehensive Cancer Center Core Support Grant - Cancer Chemoprevention Program
Comprehensive Cancer Center Core Support Grant - Cancer Chemoprevention Program
Comprehensive Cancer Center Core Support Grant - Cancer Clinical Investigator Team Leadership Award
Comprehensive Cancer Center Core Support Grant - Cancer Clinical Investigator Team Leadership Award (CCITLA)
Comprehensive Cancer Center Core Support Grant - Cancer Control and Population Sciences Program
Comprehensive Cancer Center Core Support Grant - Cancer Control and Population Sciences Program
Comprehensive Cancer Center Core Support Grant - Cancer Control and Population Sciences Program
Comprehensive Cancer Center Core Support Grant - Cancer Prevention and Control in Rural Alabama: Development of a Participatory and Integrated Action Plan
Comprehensive Cancer Center Core Support Grant - Cancer Prevention and Control in Rural Alabama: Development of a Participatory and Integrated Action Plan
Comprehensive Cancer Center Core Support Grant - Cancer Prevention and Control in Rural Alabama: Development of a Participatory and Integrated Action Plan 2.0
Comprehensive Cancer Center Core Support Grant - Clinical Protocol and Data Management Shared Facility
Comprehensive Cancer Center Core Support Grant - Clinical Protocol and Data Management Shared Facility
Comprehensive Cancer Center Core Support Grant - Clinical Protocol and Data Management Shared Facility
Comprehensive Cancer Center Core Support Grant - Comprehensive Genomics
Comprehensive Cancer Center Core Support Grant - Comprehensive Genomics
Comprehensive Cancer Center Core Support Grant - Comprehensive Genomics Shared Facility
Comprehensive Cancer Center Core Support Grant - Data & Safety Monitoring
Comprehensive Cancer Center Core Support Grant - Development Funds
Comprehensive Cancer Center Core Support Grant - Developmental Funds
Comprehensive Cancer Center Core Support Grant - Developmental Funds
Comprehensive Cancer Center Core Support Grant - Expanding Our Cancer Prevention and Control Infrastructure to Reduce Cancer and Other Chronic Disease Health Disparities in the Deep South
Comprehensive Cancer Center Core Support Grant - Experimental Therapeutics Program
Comprehensive Cancer Center Core Support Grant - Experimental Therapeutics Program
Comprehensive Cancer Center Core Support Grant - Experimental Therapeutics Program
Comprehensive Cancer Center Core Support Grant - Experimental Therapeutics Program
Comprehensive Cancer Center Core Support Grant - Fabian Supplement (QM-MSP, Ki67, and Cytomorphology of RPFNa Specimens from High Risk Women)
Comprehensive Cancer Center Core Support Grant - Gene Expression
Comprehensive Cancer Center Core Support Grant - HIV-Associated Malignancies Supplement
Comprehensive Cancer Center Core Support Grant - High Field Molecular NMR Shared Facility
Comprehensive Cancer Center Core Support Grant - High Resolution Imaging Facility
Comprehensive Cancer Center Core Support Grant - High Resolution Imaging Shared Facility
Comprehensive Cancer Center Core Support Grant - High Resolution Imaging Shared Facility
Comprehensive Cancer Center Core Support Grant - High Resolution Imaging Shared Facility
Comprehensive Cancer Center Core Support Grant - High Resolution Microscopy (Imaging)
Comprehensive Cancer Center Core Support Grant - Human Imaging Shared Facility
Comprehensive Cancer Center Core Support Grant - Human Imaging Shared Facility
Comprehensive Cancer Center Core Support Grant - Human Imaging Shared Facility
Comprehensive Cancer Center Core Support Grant - Human Imaging Shared Facility
Comprehensive Cancer Center Core Support Grant - Inflammation, Immunology and Immunotherapeutics Program
Comprehensive Cancer Center Core Support Grant - Inflammation, Immunology and Immunotherapeutics Program
Comprehensive Cancer Center Core Support Grant - Inflammation, Immunology and Immunotherapeutics Program
Comprehensive Cancer Center Core Support Grant - Major Program Leaders
Comprehensive Cancer Center Core Support Grant - Mass Spectrometry and Proteomics Shared Facility
Comprehensive Cancer Center Core Support Grant - Mass Spectrometry and Proteomics Shared Facility
Comprehensive Cancer Center Core Support Grant - Mass Spectrometry and Proteomics Shared Facility
Comprehensive Cancer Center Core Support Grant - Mass Spectroscopy
Comprehensive Cancer Center Core Support Grant - Microbiome and Gnotobiotics Shared Facility
Comprehensive Cancer Center Core Support Grant - Microbiome and Gnotobiotics Shared Facility
Comprehensive Cancer Center Core Support Grant - Microbiome and Gnotobiotics Shared Facility
Comprehensive Cancer Center Core Support Grant - Molecular Biology/Rec. Protein
Comprehensive Cancer Center Core Support Grant - Molecular NMR
Comprehensive Cancer Center Core Support Grant - NCI Clinical Trial Reporting Program (CTRP) Support
Comprehensive Cancer Center Core Support Grant - Neuro-Oncology Program
Comprehensive Cancer Center Core Support Grant - Neuro-Oncology Program
Comprehensive Cancer Center Core Support Grant - Pilot Projects
Comprehensive Cancer Center Core Support Grant - Planning & Evaluation
Comprehensive Cancer Center Core Support Grant - Planning and Evaluation
Comprehensive Cancer Center Core Support Grant - Planning and Evaluation
Comprehensive Cancer Center Core Support Grant - Planning and Evaluation
Comprehensive Cancer Center Core Support Grant - Population Health Assessment in Cancer Center Catchment Areas
Comprehensive Cancer Center Core Support Grant - Population Health Assessment in Cancer Center Catchment Areas
Comprehensive Cancer Center Core Support Grant - Preclinical Imaging Shared Facility
Comprehensive Cancer Center Core Support Grant - Preclinical Imaging Shared Facility
Comprehensive Cancer Center Core Support Grant - Preclinical Imaging Shared Facility
Comprehensive Cancer Center Core Support Grant - Prevalence and Genotype Distribution of Cervical and Oral HPV Infection in HIV+Brazilian Women
Comprehensive Cancer Center Core Support Grant - Proteomics
Comprehensive Cancer Center Core Support Grant - Protocol Review and Monitoring System
Comprehensive Cancer Center Core Support Grant - Protocol Review and Monitoring System
Comprehensive Cancer Center Core Support Grant - Protocol Review and Monitoring System
Comprehensive Cancer Center Core Support Grant - Protocol Review and Monitoring System
Comprehensive Cancer Center Core Support Grant - Protocol Review/Monitoring
Comprehensive Cancer Center Core Support Grant - Protocol Specific
Comprehensive Cancer Center Core Support Grant - Recruitment & Retention
Comprehensive Cancer Center Core Support Grant - Recruitment and Retention Shared Facility
Comprehensive Cancer Center Core Support Grant - Recruitment and Retention Shared Facility
Comprehensive Cancer Center Core Support Grant - Recruitment and Retention Shared Facility
Comprehensive Cancer Center Core Support Grant - Self-Collection & HPV Testing in Unscreened Women: A Feasibility Study in Brazil
Comprehensive Cancer Center Core Support Grant - Senior Leadership
Comprehensive Cancer Center Core Support Grant - Structural Biology Shared Facility
Comprehensive Cancer Center Core Support Grant - Structural Biology Shared Facility
Comprehensive Cancer Center Core Support Grant - Structural Biology Shared Facility
Comprehensive Cancer Center Core Support Grant - Tissue Procurement
Comprehensive Cancer Center Core Support Grant - Tissue Procurement Shared Facility
Comprehensive Cancer Center Core Support Grant - Tissue Procurement Shared Facility
Comprehensive Cancer Center Core Support Grant - Tissue Procurement Shared Facility
Comprehensive Cancer Center Core Support Grant - Transgenic Animal
Comprehensive Cancer Center Core Support Grant - Transgenic Animal Shared Facility
Comprehensive Cancer Center Core Support Grant - Transgenic Animal Shared Facility
Comprehensive Cancer Center Core Support Grant - Transgenic Animal Shared Facility
Comprehensive Cancer Center Core Support Grant - caBIG Technology Assessment and Implementation Planning
Contemporary Therapeutics for Anaplastic Gliomas
Contemporary Therapeutics for Anaplastic Gliomas - Administrative Core
Contemporary Therapeutics for Anaplastic Gliomas - Animal Models
Contemporary Therapeutics for Anaplastic Gliomas - Brain Tumor Tissue Core
Contemporary Therapeutics for Anaplastic Gliomas - Clinical Trials Core
Contemporary Therapeutics for Anaplastic Gliomas - Project #1
Contemporary Therapeutics for Anaplastic Gliomas - Project #2 - Death Receptor Antibody Therapy for Anaplastic Glioma
Contract Orientation Meeting with NCI, Office of Acquistions
Cooperative Human Tissue Network
Credentialing Murine Models for Glioblastoma Preclinical Drug Development
Cytochrome C Oxidase in Malignant Gliomas
Cytoplasmic Multimerization of the RNA-Binding Protein HuR is Oncogenic in Glioma
DNA Topoisomerase-Camptothecin Interactions
Death Receptor-Mediated Apoptosis and Therapy Strategies in Ovarian Cancer
Deciphering How Esco2 Loss Acts as a Penetrance Modifier
Deep South Network for Cancer Control
Deep South Network for Cancer Control
Determination of Mussashi 1/CD44v6 Signaling in Mesenchymal Glioma Stem Cells
Determining the Influence Genomic Instability During Embryogenesis has on Tumor Penetrance
Developing Novel Combination Therapies for Pancreatic Cancer
Developing Therapy for the Treatment of Cholangiocarcinoma
Development, Implementation, and Evaluation of a Smoking Cessation Intervention Tailored to Rural Young Adult African American Men: Toward Scalability
Dietary Intervention of Non-Classical Wnt Signaling
Discovery of Novel Drug Targets for Breast Cancer
Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response
Early Life Prevention of Breast Cancer with Combined Epigenetic Botanicals
Engineered HSV for the Treatment of Malignant Glioma
Engineered HSV for the Treatment of Malignant Glioma - Core A. Administrative Core
Engineered HSV for the Treatment of Malignant Glioma - Project 1
Engineered HSV for the Treatment of Malignant Glioma - Project 2 - Radiation Enhancement of HSV Anti-Tumor Effects
Engineered HSV for the Treatment of Malignant Glioma - Project 3 - Preclinical Evaluation of Oncolytic HSV for Anaplastic Glioma Therapy
Engineered HSV for the Treatment of Malignant Glioma - Project 4 - Lessons from the O.R.: Using Clinical Biologic Correlates to Inform HSV Trial Design
Engineered HSV for the Treatment of Malignant Gliomas - Core B (Animal Model) - Experimental Glioma Animal Models
Enhanced Immunotherapy by Targeting the Pros1:Macrophage Mer Axis
Enhancing Physical Activity After Breast Cancer Diagnosis: Randomized Trial
Epigenetics of Tea Polyphenols in Cancer Prevention
Evaluating Bioactive Food Components in Obesity and Cancer Prevention
Exploring Effects of Weight Loss on Ductal Carcinoma In Situ
Exploring the Impact of Negative Energy Balance in Men with Prostate Cancer
FOXP3-microRNA146-NFkB Axis in Tumor Suppression
Find Your BEAT: Toolkit to Increase Physical Activity in Rural Cancer Survivors
Focal Adhesion Kinase (FAK) in Human Neuroblastoma
Food and Eating Behaviors of Head and Neck Cancer Patients
Gene-Engineered and Targeted Stem Cell Therapy for Myeloma
Glycan Control of Stem Cell-Associated Pathways in Pancreatic Cancer
Glycosylation-dependent Mechanisms Regulating Ovarian Tumor cell Phenotype
HHSN26100002 Efficacacy of a Multi-Antegen Vaccine in the Prevention of MethyInitrosourea-Introduced Mammary Cancers (ER+) in Female Sprague-Dawley Rats
HHSN26100003 Chemopreventive Effects in Both Standard Chow Diets and High Fat Diets of Known Positive and Negative Chemopreventative Agents Employing Both High Risk (But Histologically Normally) Mammary Epithelium and Mammary Cancers Including Correlative Biomarkers
HHSN26100004 TORFP IV/IV 2013-3 Evaluation of GLG-302, a STAT3 Antagonist in the Prevention of Mammary Cancer
HHSN26100005 TORFP IV/IV 2013-4 Efficacy of Metformin in the Methylnitrosourea-Induced Model EF+ Mammary Carcinogenesis when Animals are Placed on Different Diets: Standard Diet, High Fat Diet, and High Fructose Diet
HHSN26100006 TORFP 2014-3I Evaluation of the Prevention by Actoplus/Met (Pioglitazone and Metformin) of ER+ and ER- Mammary Cancer Occurring in Rodents on a High-Fat Diet
HHSN26100007 TORFP 2014-5I Effect of Bazedoxifene Either Alone or in Combination with an Aromatase Inhibitor or Conjugated Estrogens (CE) in the Prevention of Mammary Cancers
HPV Clearance by Folic Acid Supplementation
HPV Clearance by Folic Acid Supplementation
Harvest for Health in Older Cancer Survivors
Heparanase In Tumor Progression, Metastasis and Chemoresistance
Heparanase Regulation of Myeloma Metastasis: Mechanism and Therapy
Heparanase Regulation of Myeloma Metastasis: Mechanism and Therapy
Heparanase Regulation of Osteolysis in Multiple Myeloma
Heparanase Regulation of Tumor Host Interactions in Myeloma and Breast Cancer
IVR-Supported Interventions for Cancer Prevention in the Deep South
Identifying Outcome Mediators of Calorie Restriction Mimetic use in Renal Cancer
Imaging Guided Surgery Using Fluorescently Labeled Cetuximab
Imaging Guided Surgery using Fluorescently Labeled Cetuximab
Imaging for Assessment and Prediction of Response to Therapy for Triple Negative Breast Cancer
Inhibiting Multiple Molecular Targets for Preventing Non-Melanoma Skin Cancer
Integrated Smoking Cessation Treatment for Low Income Community Corrections
Intra-Tumor Heterogeneity in Colorectal Cancer Progression and Treatment Response
Life after Breast Cancer Treatment: Racial Health Disparities and Chronic Pain in Breast Cancer Survivors
Loss of FLJ13639 Expression in Acute Leukemia
Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk
Maternal Epigenetic Dietary Effects on Early Breast Cancer Prevention
Maternal Epigenetic Dietary Effects on Early Breast Cancer Prevention
Maternal Epigenetic Dietary Effects on Early Breast Cancer Prevention
Mechanisms of Human Papillomavirus DNA Replication
Mechanisms of Human Papillomavirus DNA Replication
Mechanisms of Resistance to Cancer Therapeutics
Medical Record Abstraction for Pancreatic Cancer Survival Analyses
MicroRNAs for Monitoring Tumor Progression and Predicting Response to Therapy
Microbiome Based Approach to Identify the Progression Potential of CIN 2 Lesions
Microenvironmental Regulation Of Leukemia Stem Cells
Microenvironmental Regulation of Glioblastoma Angiogenesis via CHD7
Microenvironmental Regulation of Leukemia Stem Cells
Mitigating Long-term Treatment-related Morbidity in Childhood Cancer Survivors
Mitochondria and Carcinogenesis
Mitochondria and Mutagenesis
Mitochondria in Prostate Cancer Diversity
Mitochondrial DNA and Prostate Cancer in African Americans
Molecular Characterization of Myeloma and Related Asymptomatic Precursor States
Molecular Determinants of Breast Cancer Malignancy
Molecular Predictors of Post-Mastectomy Breast Cancer Loco-Regional Recurrence
Molecular Therapeutics for Anaplastic Gliomas
Molecular Therapeutics for Anaplastic Gliomas - Career Development
Molecular Therapeutics for Anaplastic Gliomas - Core A
Molecular Therapeutics for Anaplastic Gliomas - Core C
Molecular Therapeutics for Anaplastic Gliomas - Pilot Projects
Molecular Therapeutics for Anaplastic Gliomas - Project 3
Molecular Therapeutics for Anaplastic Gliomas - Project 4
Molecular Therapeutics for Anaplastic Gliomas - Project 4 Consortium
Molecular Therapeutics for Anaplastic Gliomas - Supplement for Ester Suswam
Molecular Therapeutics for Anaplstic Gliomas - Core D
Morehouse School of Medicine/Tuskegee University/Univ. of Alabama Cancer Center Partnership
Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership
Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: (Admin Supplement) to Support Development of PDX at UAB CCC
Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Administrative Core
Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Bioethics Shared Resource
Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Biostatistics/Bioinformatics Shared Resource
Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Outreach Core
Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Pilot Research Project: IMPaCT 2.0
Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Planning and Evaluation Core
Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Project 1: CD24-Dependent Inactivation of Mutant p53 in Metastatic Castration-Resistant Prostate Cancer
Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Project 2: Molecular Regulation of Kaiso in Prostate Cancer
Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Research Education Core
Multi-Modal Lysosomotropic Death Therapy for Malignant Peripheral Nerve Sheath Tumors
Multimodal Study Of Cognitive Impairment Following Radiation Therapy for Locally Advanced Head And Neck Cancer
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M Study
NCI-CONNECT (Comprehensive Oncology Network Evaluating Rare CNS Tumors) Collaborative Agreement
NCTN Deep South Research Consortium
NCTN Deep South Research Consortium
NCTN Deep South Research Consortium
NCTN Deep South Research Consortium
Negative Impact of RNA Destabilizer Tristetraprolin on Glioma Growth
Novel Anti-HER3 Strategy for Pancreatic Cancer
Novel Combinatorial Therapeutic Approach for Prostate Cancer
Novel Fluorinated Amino Ester Prodrugs For PET Imaging Of Gliomas
Novel Heparanase Inhibitors for Cancer Therapy
Novel Role for Shed Syndecan 1 in Promoting an Aggressive Tumor Phenotype
Novel Role of Compensatory Proliferation in Human Brain Tumor
Novel Treatment of NF-1 Associated Malignant Peripheral Nerve Sheath Tumors
Nucleoporin NUP205-Driven Novel Pathway in Melanoma Tumor Growth and Metastasis
Obesity Affects Immunity to Kidney Cancer
Oncolytic Immunotherapy Using Chimeric HSV C134: A Phase I Trial and Establishment of Response Indicators in Recurrent Glioma Patients
Optical Imaging of Primary and Regional Melanoma to Guide Surgical Resection
Osteopontin and Microenvironment of Initiated Cells
PREVENT Cancer Preclinical and Drug Development Program
PREVENT Cancer Preclinical and Drug Development Program
PRMT1-Mediated Metabolic Reprogramming in Leukemia Progression
Participatory Design of a Text Message System to Support Community Health Advisor
Personalized Therapy for p16-deficient Melanoma
Pet Tumor and Proliferation Imaging Via Cationic Amino Acid Transport
Phase-Sensitive X-Ray Breast Tomosynthesis (R09-003)
Plumbagin in Combination with Vemurafenib for BRAF-Mutant Melanoma
Post-Transcriptional Regulation Requires Phosphorylation of HuR in Gliomas
Preclinical In Vitro and In Vivo Screening Assays for Cancer Preventive Agent Development
Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers
Preclinical in Vitro and In Vivo Agent Development Assays
Predictive Molecular Markers of Colorectal Cancer
Prevention of UV-Carcinogenesis Through DNA Methylation-Dependent Immunomodulation
Prevention of UV-Carcinogenesis through DNA Repair-Dependent Immunomodulation
Promoting Weight-Loss in African American Cancer Survivors in the Deep South
Prostate, Lung, Colo-Rectal and Ovarian (PLCO) Cancer Screening Trial
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial - Prostate Cancer Progression in the PLCO Cancer Screening Trial
Protein Interactions Underlying Fas-Mediated DISC in Cholangiocarcinoma
Quadrivalent Human Papillomavirus (HPV) Vaccine in Cancer Survivors
Quantitative PET Imaging for Oncologic Immune Response Prediction
RHYTHM: Restoring Health in You (and Your Partner) Through Movement
RXR Rexinoids for Cancer Chemoprevention
RXR Rexinoids for Cancer Chemoprevention - Project 2: Design and Development of Third Generation RXR Rexinoids as Potential Chemoprevention Agents
RXR Rexinoids for Cancer Chemoprevention - Core 1: Administrative Core
RXR Rexinoids for Cancer Chemoprevention - Core 2: RXR Rexinoid Design and Synthesis
RXR Rexinoids for Cancer Chemoprevention - Core 3: Rexinoid Screening and Animal Core
RXR Rexinoids for Cancer Chemoprevention - Program Integration and Management
RXR Rexinoids for Cancer Chemoprevention - Project 1: Evaluation if UAB30 on Skin Cancer Biomarkers in Human Renal Transplant Recipients
RXR Rexinoids for Cancer Chemoprevention - Project 2: Design and Development of Third Generation RXR Rexinoids as Potential Chemoprevention Agents
RXR Rexinoids for Cancer Chemoprevention - Project 3: Molecular Targets of Rexinoid Action in Skin
Racial Disparities: Pain in Women Treated for Breast Cancer
Radiolabeled Antibodies Targeting LAT1 for Imaging and Therapy of Prostate Cancer
Regulation of Beta1 Integrin Glycosylation by Ras
Regulation of Polycomb Repressive Complex 1 by EZH2 Regulated microRNAs in Cancer
Regulation of the Kidney Cancer Epigenome by Oncometabolite L-2-Hydroxyglutarate
Research Training Program in Basic and Translational Oncology
Research Training Program in Basic and Translational Oncology
Research Training Program in Surgical Oncology
Research Training Program in Surgical Oncology
Research Training Program in Surgical Oncology
Resistance of CML Stem Cells to Imatinib (Gleevec)
Role of Fumarate Hydratase in Renal Hypoxia and Tumorigenesis
Role of Genetic Susceptibility in Therapy-Related Subsequent Malignancies
Role of Gut Microbe Composition in Psychosocial Symptom Response to Exercise Training in Breast Cancer Survivors
Role of Microbiota in Therapy to Ovarian Cancer
Role of NF-kB in Hematopoietic Stem Cells and Leukemia-Initiating Cell Formation
Role of NMI in Retarding Breast Tumor Growth
Role of Oncometabolite L-2 Hydroxyglutarate in Reprogramming Renal Cell Carcinoma Metabolism
Role of Transcriptional Corepressor CtBP1 in Prostate Cancer Progression
Roles of Semaphorin Signaling in Breast Cancer Racial Disparities
Rural Breast Cancer Survivors Intervention
SPORE in Breast Cancer
SPORE in Breast Cancer - Administrative Core
SPORE in Breast Cancer - Biostatistics Core
SPORE in Breast Cancer - Career Development
SPORE in Breast Cancer - Diversity Supplement
SPORE in Breast Cancer - Pilot Projects
SPORE in Breast Cancer - Project 1
SPORE in Breast Cancer - Project 2
SPORE in Breast Cancer - Project 3
SPORE in Breast Cancer - Project 4
SPORE in Breast Cancer - Project 5
SPORE in Breast Cancer - Tissue Core
STRAP and Smad 7 Signaling in Colorectal Carcinomas
SUMOylation and Cell Sensitivity to Top1 Poisons
Sialylation-dependent Mechanisms Driving Pancreatic Cancer Progression
Sowing the Seeds of Health: A Program for Latinas
Surgical Oncology Research Training Program
Synergistic Targeted Therapy of Antibody-Drug Conjugates for Triple-Negative Breast Cancer
T001 HHSN2610001 Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers - Kick Off Meeting - Contract Orientation and Kick Off Meeting
T002 HHSN2610002 Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers - Task Order 2015 E-02 - Evaluation of Agents/Protocols that Inhibity the Two Major Pathways Involved in Human Urinary Bladder Cancer [PI3K, EGFR] and Protocols to Reduce their Toxicity
T003 HHSN2610003 Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers - Task Order 2015 E-07 - Evaluation of the Cancer Prevention Efficacy of GLG-302
T004 HHSN2610004 Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers - Immunologic Effects of NSAIDs With and Without a Vaccine in Colon Cancer Prevention
T005 HHSN26100005 TORFP 2017-E04 Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers - Evaluation of "Clinical-Ready" Agents (Bazedoxifene and Lapatinib) in Combination for the Prevention of ER+ and ER- Mammary Cancers
T007 HHSN26100007 TORRP-EZ-2018-E01 Evaluation of STAT-3 ANtagonists in the Prevention of Mammary Cancer
T008 HHSN26100009 TORFP 2018-E04 Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers - Evaluating Whether a Concurrent Retinoid X Receptor Agonist Can Enhance the Efficacy of HER2-IGFPB2-IGFLR Vaccine in Eliminating Existing Ductal Carcinoma in Situ and Preventing Progression of Invasive Breast Cancer
T009 HHSN26100008 TORFP 2018-E03 Prevention of Urinary Bladder Cancer with Two "Clinically-Ready" Agents (Everolimus and Naproxen) when Administered in Combination
T010 HHSN26100010 TORFP 2018-E07 Preclinical Development of a Chemopreventive Agent, 4-Methylumbelliferone (4-MU)
T011 HHSN26100011 TORFP 2018-E08 Further Development of Multi-Antigen Vaccines for the Primary and Secondary Prevention of Bladder Cancer
TGF-beta Polymorphisms and Breast Cancer in Families
TGFBR1 Signaling in Colorectal Cancer
TORFP 2019-E03 75N91019D00019 75N91019F00130 Evaluation of Two Different Classes of Compounds (STAT3 Inhibitors and SERMs) for Prevention of Urinary Bladder Cancer
TORFP 2019-E04 75N91010D00019 75N91019F00132 Colorectal Cancer Prevention by Novel EPA Analogue TP-252 and Naproxen in FAP and Lynch Syndrone Models
TORFP 2019-E06 75N91019D00019 75N91019F00131 Further Development of Colovac, a Multi-Antigen Multi-Peptide Vaccine, for Colon Cancer Prevention
Targeted Therapy for Breast Cancer with Osteolytic Bone Damage
Targeted Treatment of Metastatic Gastroenteropancreatic Neuroendocrine Tumors
Targeting Metabolic Checkpoints in the Tumor Microenvironment to Boost Efficacy of Anti-CTLA-4
Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma
Testing Scalable, IVR-Supported Cancer Prevention Interventions in the Rural Alabama Black Belt
The Interplay of Behavior, Environment, and Microbiota in Colorectal Cancer Risk
The Natural History of CMV-Related Hearing Loss and the Feasibility of CMV Screening as Adjunct to Hearing Screening in the Newborn
The Role of CK2 in Glioblastoma Development
The Role of Exosome Heparanase and miRNAs as Biomarkers for Myeloma
The Thrombospondin1-TGF-Beta Axis in Multiple Myeloma
Therapy of Pancreatic Cancer With 212Pb-Labeled B7-H3 Specific Ab and LDE225
Third International Meeting on Genetic Syndromes of the Ras/MAPK Pathway
Topical Chemoprevention of Skin Cancer Biomarkers
Tumorigenic Role of Mitochondria in African-American Women
UAB / UMN SPORE in Pancreatic Cancer
UAB / UMN SPORE in Pancreatic Cancer - Career Development
UAB / UMN SPORE in Pancreatic Cancer - Core A
UAB / UMN SPORE in Pancreatic Cancer - Core B
UAB / UMN SPORE in Pancreatic Cancer - Core C
UAB / UMN SPORE in Pancreatic Cancer - Core D
UAB / UMN SPORE in Pancreatic Cancer - Development
UAB / UMN SPORE in Pancreatic Cancer - Project 1
UAB / UMN SPORE in Pancreatic Cancer - Project 2
UAB / UMN SPORE in Pancreatic Cancer - Project 3
UAB / UMN SPORE in Pancreatic Cancer - Project 4
UAB Cancer Prevention and Control Training Program (T32)
UAB Cancer Research Experiences for Students
UAB Cancer Research Experiences for Students (CaRES)
UAB Comprehensive Cancer Center Early Stage Investigator Recruitment
Urinary Metabolites of Cranberry that Protect against Bladder Cancer
Utilizing microRNA-146a to Block Triple-Negative Breast Cancer Cell Colonization
Validating a Novel Biomarker of Clinical Progression and Survival in CLL
Vegetable Garden Feasibility Trial to Promote Function in Older Cancer Survivors
Wnt5a and TGF-beta in Mammary Development and Cancer
Zambian Cervical Cancer Research Capacity Initiative
rAAV Vaccine Vector
